Hand-out
Press Releases
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
EMERYVILLE, Calif., March 3, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that
